Valeant Pharmaceuticals

Brand

Something Missing?

Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) is a multinational specialty pharmaceutical company based in Laval, Canada. It develops, manufactures, and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology, and branded generics. Valeant owns Bausch & Lomb, one of the world's largest suppliers of eye health products.

Founded in California in 1959 as ICN Pharmaceuticals, Valeant grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson and for a short period of time in 2015 was the most valuable company in Canada. Its largest acquisitions were Bausch & Lomb in 2013 and Salix Pharmaceuticals in 2015. Valeant also tried to acquire Actavis and Cephalon and merge with Allergan in 2014, but failed and was sued for insider trading prior to their bid.

Subject ID: 93676

More

Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) is a multinational specialty pharmaceutical company based in Laval, Canada. It develops, manufactures, and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology, and branded generics. Valeant owns Bausch & Lomb, one of the world's largest suppliers of eye health products.

Founded in California in 1959 as ICN Pharmaceuticals, Valeant grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson and for a short period of time in 2015 was the most valuable company in Canada. Its largest acquisitions were Bausch & Lomb in 2013 and Salix Pharmaceuticals in 2015. Valeant also tried to acquire Actavis and Cephalon and merge with Allergan in 2014, but failed and was sued for insider trading prior to their bid.

Subject ID: 93676

Less

Subject ID: 93676